标题
Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population
作者
关键词
-
出版物
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
Volume 23, Issue 2, Pages 105-115
出版商
SAGE Publications
发表日期
2015-08-25
DOI
10.1177/1076029615600789
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis
- (2015) Fanny Turon et al. JOURNAL OF HEPATOLOGY
- Incidence ofCALRmutations in patients with splanchnic vein thrombosis
- (2014) Karl Haslam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: A role for the JAK2 V617F mutation re-evaluation
- (2013) Donatella Colaizzo et al. THROMBOSIS RESEARCH
- Thrombophilic polymorphisms – factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T – in Tunisian patients with cerebral venous thrombosis
- (2012) Olfa Ben Salem-Berrabah et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders
- (2012) Tanima De et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The JAK2 V617F mutation in patients with cerebral venous thrombosis
- (2012) S. M. PASSAMONTI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Frequency of Genetic Mutations Associated with Thromboembolism in the Western Black Sea Region
- (2011) Esra Tug et al. INTERNAL MEDICINE
- Prothrombin G20210A and Factor V Leiden Polymorphisms in Stroke
- (2011) Thierry Paluku They-They et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Prevalence of factor V Leiden in south Tunisian blood donors
- (2011) Lobna Maalej et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION
- (2011) Mehrez Mehrez M. Jadaon Mediterranean Journal of Hematology and Infectious Diseases
- EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION
- (2011) Mehrez M. Jadaon Mediterranean Journal of Hematology and Infectious Diseases
- Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco
- (2010) Thierry Paluku They-They et al. ANNALS OF HUMAN BIOLOGY
- Genetic Mutations in Turkish Population With Pulmonary Embolism and Deep Venous Thrombosis
- (2010) Elif Kupeli et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Factor V Leiden thrombophilia
- (2010) Jody Lynn Kujovich GENETICS IN MEDICINE
- JAK2V617F mutation in patients with thrombosis: to screen or not to screen?
- (2010) S. G. XAVIER et al. International Journal of Laboratory Hematology
- Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals
- (2010) Ali A. Dashti et al. MOLECULAR BIOLOGY REPORTS
- Population genetics of venous thromboembolism
- (2010) Elvira Grandone et al. THROMBOSIS AND HAEMOSTASIS
- JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- (2009) F. Dentali et al. BLOOD
- Low prevalence of the JAK2V617F in patients with ischemic stroke or cerebral venous thrombosis
- (2009) Sandra Guerra Xavier et al. BLOOD COAGULATION & FIBRINOLYSIS
- The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with β-thalassemia major
- (2009) Suleimman A Al-Sweedan et al. BLOOD COAGULATION & FIBRINOLYSIS
- JAK2V617F Mutation Associated with Cerebral Venous Thrombosis: A Report of Five Cases
- (2009) G. Godeneche et al. CEREBROVASCULAR DISEASES
- High Incidence of Factor V Leiden and Prothrombin G20210A in Healthy Southern Italians
- (2009) Gianluca Sottilotta et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis
- (2009) Sandra Guerra Xavier et al. DIGESTIVE DISEASES AND SCIENCES
- JAK2V617F Mutation Screening as Part of the Hypercoagulable Work-up in the Absence of Splanchnic Venous Thrombosis or Overt Myeloproliferative Neoplasm: Assessment of Value in a Series of 664 Consecutive Patients
- (2009) Animesh Pardanani et al. MAYO CLINIC PROCEEDINGS
- Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms
- (2008) Alessia Fiorini et al. AMERICAN JOURNAL OF HEMATOLOGY
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- (2008) J.-J. Kiladjian et al. BLOOD
- Thrombophilic polymorphisms in Israel
- (2008) Avshalom Zoossmann-Diskin et al. BLOOD CELLS MOLECULES AND DISEASES
- Prevalence of theJAK2V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms
- (2008) Tommaso Za et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Prevalence of Methylenetetrahydrofolate Reductase 677 C-T, Factor V 1691 G-A, and Prothrombin 20210 G-A Mutations in Healthy Populations in Sétif, Algeria
- (2008) Romyla Bourouba et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- JAK2V617F Mutation in Patients with Portal Vein Thrombosis
- (2008) Yusuf Bayraktar et al. DIGESTIVE DISEASES AND SCIENCES
- Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry
- (2008) Vanessa Roldan et al. THROMBOSIS RESEARCH
- TheJAK2V617Ftyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis
- (2007) C. GOULDING et al. International Journal of Laboratory Hematology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started